Cancer vaccines based on mRNA advance, despite US cuts reut.rs/43q8ruD
Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma and early promise in pancreatic and brain cancers once ​considered impervious to immune system assault.
